Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer’s disease

OBJECTIVE: Investigate efficacy of 13.3 mg/24 h rivastigmine patch in patients with severe Alzheimer’s disease on Alzheimer’s Disease Cooperative Study–Activities of Daily Living Scale–Severe Impairment Version items and domains. METHODS: Retrospective analysis of the 24-week, randomized, double-bli...

Descripción completa

Detalles Bibliográficos
Autores principales: Micca, Joseph L, Galvin, James E, Velting, Drew M, Meng, Xiangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607239/
https://www.ncbi.nlm.nih.gov/pubmed/26770753
http://dx.doi.org/10.1177/2050312114561569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607239/
https://www.ncbi.nlm.nih.gov/pubmed/26770753
http://dx.doi.org/10.1177/2050312114561569

Ejemplares similares